SOURCE-LINKED INTELLIGENCE
FIRST-IN-CLASS MYC INHIBITOR: THE MAKING OF A BREAKTHROUGH CANCER THERAPY
of life while establishing itself as a European leader biotech in MYC targeting. MYC, Undruggable target, Cell-penetrating mini-protein drug, First-in-class, First-in-modality, Companion diagnostic, Machine learning-enabled biomarkers discovery, Omics
Read original source ↗ Open in workspace
- recordType
- award
- status
- SIGNED
- region
- EU
- value
- 2494504
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T02:21:08.944Z. This is not the publication date.